ZYME - Zymeworks Inc. Common Stock logo

ZYME

Zymeworks Inc. Common Stock

Zymeworks Inc. develops biotherapeutics targeting cancer, inflammation, and autoimmune diseases using platforms like Azymetric and Drug Conjugate. Key products include bispecific antibodies for HER2-expressing tumors and antibody-drug conjugates for various cancers.

โš•๏ธ Healthcare NASDAQ Listed 2017 $ USD
$1,000 invested 5 years ago โ†’$802today

Score Overview

1 Year
Score
Net Growth-84.88%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-64.96%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score4.6
Net Growth29.20%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth39.16%
Rev Trend60%
Revenue Consistencyโ€”
All Time
Score
Net Growth-12x
Net Trend22%
Net Income Consistency
Rev Growth-28.27%
Rev Trend56%
Revenue Consistency

See the full market ranking โ†’

Zymeworks Inc. Common Stock fundamental performance

Between 2020 and 2025, revenue grew from $ 38M to $ 105M and net income went from -$ 180M to -$ 81M. Revenue increased in 3 of those 5 years; net income in 2.

Across Zymeworks Inc. Common Stock's full reported history, from 2017 to 2025, revenue grew from $ 51M to $ 105M and net income went from -$ 10M to -$ 81M. Revenue increased in 56% of the years measured; net income in 22%.

Zymeworks Inc. Common Stock currently holds a 5-year HDB Score of 4.6 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 24.93โ€”
1 Year2025-08-12
$ 13.0291.47%
5 Years2021-08-12
$ 31.09-19.81%
All Time2017-04-28
$ 13.0091.77%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 37M-$ 149M$ 270.69B
2025$ 105M-$ 81M$ 228M
2024$ 76M-$ 122M$ 225M
2023$ 76M-$ 118M$ 374M
2022$ 412M$ 124M$ 492M
2021$ 26M-$ 211M$ 252M
2020$ 38M-$ 180M$ 426M
2019$ 29M-$ 145M$ 298M
2018$ 53M-$ 36M$ 200M
IPO2017$ 51M-$ 10M$ 87M

Explore beyond ZYME

You're looking at Zymeworks Inc. Common Stock. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies